The association between fingolimod and mental health outcomes in a cohort of Multiple Sclerosis patients with stress
CONCLUSIONS: Close monitoring of mental health is required for patients with MS using disease-modifying therapies.PMID:37458640 | DOI:10.26355/eurrev_202307_32955
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Authors: O S Gammoh A Al-Smadi A Alqudah S Al-Habahbeh F Weshah W Ennab A-E Al-Shudifat M-H Bj ørk Source Type: research
More News: Anxiety | Depression | Drugs & Pharmacology | Gilenya | Insomnia | Men | Middle East Health | Multiple Sclerosis | Psychiatry | Study